<div><div></div><div>ENSC (Ensysce Biosciences, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q1'26, revenue estimate is 1.90 million USD with EPS (earnings per share) anticipated at (0.73) USD. Learn more details at .Revenue &amp; EPS values are provided in USD<div><table><thead><tr><th></th><th>Q1'25</th><th>Q2'25</th><th>Q3'25</th><th>Q4'25</th><th>Q1'26</th></tr></thead><tbody><tr><td>Revenue Reported</td><td>1.31 M</td><td>—</td><td>493.10 K</td><td>1.90 M</td><td>—</td></tr><tr><td>Revenue Estimate</td><td>—</td><td>650.00 K</td><td>700.00 K</td><td>502.97 K</td><td>1.90 M</td></tr><tr><td>Revenue Surprise</td><td></td><td></td><td>-29.56%</td><td>+277.76%</td><td></td></tr><tr><td>EPS Reported</td><td>(1.39)</td><td>(0.79)</td><td>(1.29)</td><td>(0.75)</td><td></td></tr><tr><td>EPS Estimate</td><td>(3.02)</td><td>(1.01)</td><td>(0.82)</td><td>(1.26)</td><td>(0.73)</td></tr><tr><td>EPS Surprise</td><td>+53.90%</td><td>+22.17%</td><td>-56.36%</td><td>+40.48%</td><td></td></tr></tbody></table></div><section>Disclaimer<div>Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.</div></section></div></div>

ENSC

ARKG

Ensysce Biosciences, Inc. (ENSC) will announce its Q1'26 earnings on May 18 at 8:00 AM ET. The revenue estimate is $1.90 million, with an anticipated EPS of $(0.73). Previous quarters showed varying revenue and EPS results, with notable surprises in EPS estimates. For more details, refer to the provided data.

TradingView

Ensysce Biosciences

Ark Genomic Revolution ETF

Health Care Select Sector SPDR

iShares Global Healthcare

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

iShares US Pharma

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

VG Health

Ensysce Biosciences - CW22

ENSC Q1'26 Earnings: EPS estimate is (0.73) USD